Penumbra Inc (NYSE:PEN) CEO Adam Elsesser Sells 8,000 Shares of Stock

Penumbra Inc (NYSE:PEN) CEO Adam Elsesser sold 8,000 shares of the business’s stock in a transaction on Monday, August 12th. The stock was sold at an average price of $149.24, for a total value of $1,193,920.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Adam Elsesser also recently made the following trade(s):

  • On Thursday, July 11th, Adam Elsesser sold 8,000 shares of Penumbra stock. The stock was sold at an average price of $171.84, for a total value of $1,374,720.00.
  • On Tuesday, June 11th, Adam Elsesser sold 8,000 shares of Penumbra stock. The stock was sold at an average price of $165.08, for a total value of $1,320,640.00.

Shares of PEN stock traded down $0.93 during mid-day trading on Thursday, hitting $147.57. The company’s stock had a trading volume of 1,443 shares, compared to its average volume of 525,520. Penumbra Inc has a 52-week low of $110.84 and a 52-week high of $185.70. The company has a 50-day moving average of $165.79. The company has a debt-to-equity ratio of 0.10, a quick ratio of 4.33 and a current ratio of 6.23. The firm has a market capitalization of $5.18 billion, a PE ratio of 289.71, a price-to-earnings-growth ratio of 8.52 and a beta of 0.65.



Penumbra (NYSE:PEN) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.27 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.21 by $0.06. Penumbra had a return on equity of 6.80% and a net margin of 3.03%. The firm had revenue of $134.20 million during the quarter, compared to analysts’ expectations of $130.67 million. During the same quarter in the previous year, the business earned $0.15 earnings per share. The company’s revenue was up 22.4% on a year-over-year basis. As a group, equities research analysts predict that Penumbra Inc will post 0.9 EPS for the current fiscal year.

Several equities research analysts have commented on PEN shares. ValuEngine downgraded Penumbra from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. HC Wainwright reissued a “buy” rating on shares of Penumbra in a report on Wednesday, April 17th. JPMorgan Chase & Co. raised Penumbra from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $140.00 to $170.00 in a report on Thursday, May 30th. Bank of America boosted their target price on Penumbra from $150.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, June 13th. Finally, Wells Fargo & Co boosted their price target on Penumbra from $180.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, August 1st. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $167.14.

Several hedge funds have recently bought and sold shares of PEN. Janus Henderson Group PLC increased its position in Penumbra by 3.6% during the first quarter. Janus Henderson Group PLC now owns 78,229 shares of the company’s stock valued at $11,500,000 after acquiring an additional 2,683 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Penumbra by 19.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 59,538 shares of the company’s stock valued at $7,277,000 after acquiring an additional 9,614 shares during the last quarter. Redwood Investments LLC increased its position in Penumbra by 20.9% during the first quarter. Redwood Investments LLC now owns 115,406 shares of the company’s stock valued at $16,966,000 after acquiring an additional 19,978 shares during the last quarter. KAMES CAPITAL plc increased its position in Penumbra by 22.8% during the second quarter. KAMES CAPITAL plc now owns 14,675 shares of the company’s stock valued at $2,345,000 after acquiring an additional 2,728 shares during the last quarter. Finally, Swiss National Bank increased its position in Penumbra by 3.5% during the first quarter. Swiss National Bank now owns 56,600 shares of the company’s stock valued at $8,321,000 after acquiring an additional 1,900 shares during the last quarter. Hedge funds and other institutional investors own 90.29% of the company’s stock.

About Penumbra

Penumbra, Inc designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the ACE and the 3D Revascularization Device brands.

See Also: Reverse Stock Split

Insider Buying and Selling by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra and related companies with MarketBeat.com's FREE daily email newsletter.